Free UK delivery on orders over £50·Next Day available·Shipping info
KPV 5mg
Peptide

KPV 5mg

Tripeptide α-MSH fragment researched for anti-inflammatory, immunomodulating, and tissue-healing properties.

£20
per vial · research use only
Purity
≥98%
Form
Lyophilised Powder
Storage
-20°C
Code
KPV
MW
340 Da
Sequence
Lys-Pro-Val
Anti-InflammatoryImmunomodulatorα-MSHGut Health

What is KPV?

KPV (Lys-Pro-Val) is a bioactive tripeptide fragment derived from α-MSH. It is researched for its potential anti-inflammatory, immunomodulating, and tissue-healing properties, with particular interest in gut health and skin repair pathways.

Key Features

  • Melanocortin receptor-mediated anti-inflammatory action
  • Gut lining integrity research compound
  • Skin healing and tissue repair pathway
  • High purity ≥98% verified by RP-HPLC

Mechanism of Action

KPV acts on melanocortin receptors (MC1R, MC3R) to modulate NF-κB inflammatory signalling pathways. Research suggests it may reduce pro-inflammatory cytokine production, support intestinal barrier integrity, and promote tissue repair mechanisms.

Research Applications

  • Inflammatory pathway modulation studies
  • Gut barrier function and intestinal health research
  • Skin repair and wound healing investigation
  • Immune balance and immunomodulation research
  • Recovery and anti-inflammatory peptide studies

Reconstitution Guide

Reconstitute with 2ml bacteriostatic water. Store at 2–8°C after reconstitution and use within 28 days.

Research Use Only. For research use only. Not for human or veterinary use. All products are intended solely for in vitro research and laboratory use. Helix Biotech does not endorse, encourage, or condone the use of any research compounds in humans or animals.

Helix Biotech

Advanced research compounds for scientific investigation. All products are intended for laboratory research purposes only.

Research Use Only Disclaimer: All products sold by Helix Biotech are intended for research purposes only. Not for human consumption. These products are not medicines or drugs and have not been approved by the MHRA or any regulatory authority for therapeutic use. Must be handled by qualified researchers in appropriate laboratory settings. Helix Biotech accepts no liability for misuse of research compounds.

© 2026 Helix Biotech Ltd. All rights reserved. Registered in England & Wales.

Research Grade · UK Dispatch · Batch Verified